Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation

Journal of Arrhythmia

Volumn 30, Issue 6, 2014, Pages 478-484

  Yamashita, Takeshi ^a   Watanabe, Eiichi ^b   Ikeda, Takanori ^c   Shiga, Tsuyoshi ^d   Kusano, Kengo F ^e   Takahashi, Naohiko ^f   Takahashi, Toshiyuki ^g   Nozaki, Akira ^h   Kasao, Masashi ⁱ   Fukatsu, Tohru ^j   Kawamura, Yuichiro ^k   Komatsu, Takashi ^l   Matsumoto, Naoki ^m   Arakawa, Tomoharu ⁿ   Sugiura, Atsushi ^o   Iwao, Tetsu ^p   Ooie, Tatsuhiko ^q  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^f OITA UNIVERSITY HOSPITAL   (Japan)

^g JR Tokyo General Hospital   (Japan)

^h Mutual Aid Association of Public School Teachers   (Japan)

ⁱ TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^j TOKYO TEISHIN HOSPITAL   (Japan)

^k ASAHIKAWA MEDICAL COLLEGE   (Japan)

^l IWATE MEDICAL UNIVERSITY   (Japan)

^m ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Daido Hospital   (Japan)

^o Hekinan Municipal Hospital   (Japan)

^p OITA RED CROSS HOSPITAL   (Japan)

^q National Hospital Organization   (Japan)

more..

Author keywords

Adverse reactions; Atrial fibrillation; Dabigatran; Digestive symptoms; Observational study

Indexed keywords

EID: 84919456547     PISSN: 18804276     EISSN: 18832148     Source Type: Journal    
DOI: 10.1016/j.joa.2014.02.011     Document Type: Article

References (15)

1. J. Stangier Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate Clin Pharmacokinet 47 2008 285 295
2. M.D. Ezekowitz, P.A. Reilly, and G. Nehmiz Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO study) Am J Cardiol 100 2007 1419 1426
3. B.I. Eriksson, O.E. Dahl, and N. Rosencher Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomized, double-blind, non-inferiority trial Lancet 370 2007 949 956
4. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
5. M. Hori, S.J. Connolly, and M.D. Ezekowitz RE-LY Investigators. Efficacy and safety of dabigatran vs. Warfarin in patients with atrial fibrillation - sub-analysis in Japanese population in RE-LY Trial Circ J 75 2011 800 805
6. S. Schulman, C. Kearon, and A.K. Kakkar RE-COVER study group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
7. C.L. Joyce, H.M. Samir, and J.G. Hillary Dyspepsia and disease burden among patients with atrial fibrillation Crit Pathw Cardiol 11 2012 14 19
8. S.J. Veldhuyzen van Zanten, and N. Chiba Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials Aliment Pharmacol Ther 23 2006 521 529
9. Ethical Guidelines for Clinical Studies. Ministry of Health, Labour and Welfare in Japan. Available from:http://www.ncgm.go.jp/rinri/main/03english.htm; July 30, 2003 [accessed 28.12.04].
10. B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 22 2001 2864 2870
11. D.M. Sobieraj, C.M. White, and S. Alikhanov The impact of antiplatelet and anticoagulant therapies on gastrointestinal symptoms in patients with atrial fibrillation: a systematic review Ann Pharmacother 46 2012 1220 1231
12. B. Cryer, and M. Feldman Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans Gastroenterology 117 1999 17 25
13. J.W. Kikendall Pill-induced esophagitis Gastroenterol Hepatol 3 2007 275 276
14. F.L. Lanza, R.H. Hunt, and A.B. Thomson Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women Gastroenterology 119 2000 631 638
15. M. Okada, and K. Okada Exfoliative esophagitis and esophageal ulcer induced by dabigatran Endoscopy 44 2012 E23 E24